New Ways to Recruit Trial Subjects

February 1, 2003

Faiz Kermani, PhD, is a budgets, proposals, and marketing executive with Chiltern International Limited, a CRO in Slough, Berkshire, UK.

, Pietro Bonacossa

Pietro Bonacossa

Pietro Bonacossa,* MBA, is a marketing executive with Chiltern International, Inc., 600 West Peachtree St., Ste. 500, Atlanta, GA 30308, (404) 522-6000, email: pietro.bonacossa@us.chiltern.com.

Applied Clinical Trials

Applied Clinical Trials, Applied Clinical Trials-02-01-2003,

To minimize time to market, sponsors must explore new subject recruitment techniques.

Clinical trials are a vital step toward bringing new drugs to market. U.S.-based clinical trial activities increased by 6% in 2001, the largest rise since 1990.¹ But although pharmaceutical companies pay close attention to the science when designing their clinical trials, few consider how they will get enough subjects to participate. As a result, most trials are plagued by delays that can cost pharmaceutical companies millions of missed sales. Delays in getting a drug to market are estimated to cost companies around $1 million a day.²

Related Content:

New Ways to Recruit Trial Subjects

Faiz Kermani, Ph.D

Pietro Bonacossa